We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UDMY
2451
DELISTED
Udemy
UDMY
| $349K | ﹤0.01% |
31,800
-1,120
| -3% | -$13.9K |
|
2452
Taysha Gene Therapies
TSHA
$1.89B
| $349K | ﹤0.01% |
121,517
-15,456
| -11% | -$32.2K |
|
|
AEAE
2453
DELISTED
AltEnergy Acquisition Corp
AEAE
| $348K | ﹤0.01% |
31,088
| – | – |
|
|
INST
2454
DELISTED
Instructure Holdings, Inc.
INST
| $347K | ﹤0.01% |
16,251
-43,297
| -73% | -$1.02M |
|
|
TECX
2455
Tectonic Therapeutic
TECX
$606M
| $346K | ﹤0.01% |
22,538
-3,255
| -13% | -$51.5K |
|
|
ITCI
2456
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $346K | ﹤0.01% |
+5,000
| New | +$344K |
|
|
KE
2457
Kimball Electronics
KE
$628M
| $346K | ﹤0.01% |
15,961
+4,452
| +39% | +$101K |
|
|
IMA
2458
ImageneBio Inc
IMA
$64.6M
| $345K | ﹤0.01% |
20,247
+16,003
| +377% | +$291K |
|
2459
PureCycle Technologies
PCT
$1.45B
| $343K | ﹤0.01% |
+55,200
| New | +$257K |
|
2460
Pixelworks
PXLW
$41.6M
| $343K | ﹤0.01% |
11,077
-236
| -2% | -$6.26K |
|
2461
CorVel
CRVL
$3.19B
| $342K | ﹤0.01% |
3,903
-3,873
| -50% | -$311K |
|
2462
Open Text
OTEX
$6.04B
| $342K | ﹤0.01% |
8,800
-143,977
| -94% | -$5.79M |
|
2463
MGE Energy Inc
MGEE
$3.08B
| $341K | ﹤0.01% |
4,331
-21,621
| -83% | -$1.51M |
|
2464
PUT
Saic
SAIC
$5.35B
| $339K | ﹤0.01% |
2,600
| – | – |
|
|
HQH
2465
abrdn Healthcare Investors
HQH
$1.32B
| $339K | ﹤0.01% |
+20,100
| New | +$343K |
|
2466
PCB Bancorp
PCB
$391M
| $338K | ﹤0.01% |
20,709
-9,665
| -32% | -$160K |
|
|
DAWN
2467
DELISTED
Day One Biopharmaceuticals
DAWN
| $337K | ﹤0.01% |
+20,412
| New | +$305K |
|
2468
Alto Ingredients
ALTO
$340M
| $336K | ﹤0.01% |
154,216
+40,106
| +35% | +$84.5K |
|
2469
Immunic
IMUX
$195M
| $336K | ﹤0.01% |
25,461
+13,812
| +119% | +$179K |
|
2470
Brookfield Infrastructure Partners
BIP
$18B
| $336K | ﹤0.01% |
10,755
-47,167
| -81% | -$1.43M |
|
2471
BancFirst
BANF
$3.8B
| $335K | ﹤0.01% |
3,800
+700
| +23% | +$62.4K |
|
2472
First Advantage
FA
$4.12B
| $334K | ﹤0.01% |
+20,617
| New | +$336K |
|
2473
Gabelli Dividend & Income Trust
GDV
$2.66B
| $334K | ﹤0.01% |
+14,539
| New | +$319K |
|
2474
South Plains Financial
SPFI
$841M
| $334K | ﹤0.01% |
12,465
+4,061
| +48% | +$109K |
|
2475
Lifeway Foods
LWAY
$481M
| $332K | ﹤0.01% |
19,266
+5,710
| +42% | +$73.1K |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.